TITLE:
Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis

CONDITION:
Cirrhosis

INTERVENTION:
colchicine

SUMMARY:

      OBJECTIVES:

      I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function
      and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.
    

DETAILED DESCRIPTION:

      PROTOCOL OUTLINE: Patients receive colchicine orally twice daily for 24 months. After the
      first month, the dose of colchicine will increase and remain at that dose for the duration
      of study.

      Patients are evaluated every 6 months during study.
    

ELIGIBILITY:
Gender: All
Age: N/A to 17 Years
Criteria:

        -  Advanced hepatic fibrosis or cirrhosis in children

          -  Not pregnant
      
